Small Business Grants: A Program That Works

WASHINGTON—A small Salt Lake City horticultural firm thought it had a marketable idea when it found strains of a fungus that significantly improves the ability of plants to absorb water and nutrients. But Native Plants Inc. didn't have enough money to conduct the necessary research, and venture capital companies weren't interested in an unknown company. Enter the Small Business Innovation Research (SBIR) program, an attempt to share a small part of the federal R&D budget with small, high-

Written byDon Veraska
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—A small Salt Lake City horticultural firm thought it had a marketable idea when it found strains of a fungus that significantly improves the ability of plants to absorb water and nutrients. But Native Plants Inc. didn't have enough money to conduct the necessary research, and venture capital companies weren't interested in an unknown company. Enter the Small Business Innovation Research (SBIR) program, an attempt to share a small part of the federal R&D budget with small, high-technology firms. The company, which is now called NPI, used a $30,000 grant from the National Science Foundation to hire a scientist to develop the concept. One year later, in 1982, NSF gave the company $177,000 for further development. Today NPI employs 400 people and is a $20 million-a-year leader in plant biotechnology. “It's a fantastic program,” said Cyrus McKell, the company's vice president for research. “It gives small firms an outlet for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies